Diabetic Gastroparesis Sanjay KalraAmit SharmaGagan Priya Editorial Open access 19 July 2018 Pages: 1723 - 1728
Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’ A Patient from Diabetes UKMarc Evans Commentary Open access 06 September 2018 Pages: 1729 - 1732
Diabetes and Diet: A Patient and Dietitian’s Perspective Carole SergeantPamela A. Dyson Commentary Open access 14 September 2018 Pages: 1733 - 1739
A Systematic Review of Ultrasound-Detected Lipohypertrophy in Insulin-Exposed People with Diabetes Haya Abu GhazalehRabab HashemHenrietta Mulnier Review Open access 16 July 2018 Pages: 1741 - 1756
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice John WildingKevin FernandoAdie Viljoen Review Open access 23 July 2018 Pages: 1757 - 1773
Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios Fernando Gomez-PeraltaCristina AbreuGuillermo E. Umpierrez Review Open access 16 August 2018 Pages: 1775 - 1789
Patients’ Perspectives of Oral and Injectable Type 2 Diabetes Medicines, Their Body Weight and Medicine-Taking Behavior in the UK: A Systematic Review and Meta-Ethnography Aikaterini PsarouHelen CooperJohn P. H. Wilding Review Open access 17 August 2018 Pages: 1791 - 1810
Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic Review and Meta-analysis of Follow-up Studies of RCTs Wenneke van WeeldenVincent WekkerRebecca C. Painter Review Open access 30 August 2018 Pages: 1811 - 1829
Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward? Harriet WarnesRebecca HelliwellRamzi A. Ajjan Review Open access 12 September 2018 Pages: 1831 - 1851
Association Trends Between Antihypertensive Drug Therapies and Diastolic Hypotension in Emirati Patients with Type 2 Diabetes: A Single-Center Retrospective Longitudinal Study Bashair M. MussaRifat A. HamoudiSalah E. Abusnana Original Research Open access 24 July 2018 Pages: 1853 - 1868
Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians’ Perspective in a Real-World Setting, Insight from a Web Survey Kota ImaiHiroki MurayamaTakahisa Hirose Original Research Open access 30 July 2018 Pages: 1869 - 1881
Adverse Drug Events Associated with sitagliptin Versus canagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Comparison Through a Meta-Analysis Pravesh Kumar BundhunFeng Huang Original Research Open access 09 August 2018 Pages: 1883 - 1895
Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM) Jan BrožDenisa Janíčková ŽďárskáMilan Kvapil Original Research Open access 09 August 2018 Pages: 1897 - 1906
Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis Pei-Jung LinElle PopeFang Liz Zhou Original Research Open access 10 August 2018 Pages: 1907 - 1918
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting Marc EvansRoopa MehtaBarrie Chubb Original Research Open access 10 August 2018 Pages: 1919 - 1930
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients Kathryn M. PfeifferAmaury BasseLaura Tesler Waldman Original Research Open access 17 August 2018 Pages: 1931 - 1944
Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis Dan QianTiantian ZhangBing Situ Original Research Open access 18 August 2018 Pages: 1945 - 1958
Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm Masahiko MiyagiHiroshi UchinoTakahisa Hirose Original Research Open access 18 August 2018 Pages: 1959 - 1968
Male Patients with Longstanding Type 2 Diabetes Have a Higher Incidence of Hypoglycemia Compared with Female Patients Feng-fei LiYing ZhangJian-hua Ma Original Research Open access 22 August 2018 Pages: 1969 - 1977
Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis Manjiri D. PawaskarLiou XuBruce Stuart Original Research Open access 24 August 2018 Pages: 1979 - 1993
Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis Xiaoling CaiXueying GaoLinong Ji Original Research Open access 28 August 2018 Pages: 1995 - 2014
RETRACTED ARTICLE: Could Intensive Blood Pressure Control Really Reduce Diabetic Retinopathy Outcomes? Evidence from Meta-Analysis and Trial Sequential Analysis from Randomized Controlled Trials Jian-Bo ZhouZhi-Hui SongJin-Kui Yang Original Research Open access 31 August 2018 Pages: 2015 - 2027
Impact of Glucose Measuring Systems and Sample Type on Diagnosis Rates of Diabetes Mellitus Markus Gabriel BlaurockAnders KallnerAstrid Petersmann Original Research Open access 05 September 2018 Pages: 2029 - 2041
Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis Stephen M. TwiggJavier EscaladaLuigi F. Meneghini Original Research Open access 10 September 2018 Pages: 2043 - 2053
Blood Glucose Monitoring and Its Determinants in Diabetic Patients: A Cross-Sectional Study in Shandong, China Abdul Marouf RaoufiXue TangChengchao Zhou Original Research Open access 11 September 2018 Pages: 2055 - 2066
Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study Natsu Otowa-SuematsuKazuhiko SakaguchiWataru Ogawa Original Research Open access 11 September 2018 Pages: 2067 - 2079
Association of Vitamin D and Parathyroid Hormone with Insulin Sensitivity, Beta Cell Function and Gestational Diabetes in Pregnancy: A Cross-Sectional, Observational Study Amit NachankarNarendra KotwalK. V. S. Hari Kumar Original Research Open access 11 September 2018 Pages: 2081 - 2090
Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar Goran PetrovskiFawziya Al KhalafAhmed El Awwa Original Research Open access 15 September 2018 Pages: 2091 - 2098
A Prospective Cohort Study on the Management of Young Patients with Newly Diagnosed Type 2 Diabetes Using Mobile Medical Applications Yabin HaoHong Xu Original Research Open access 18 September 2018 Pages: 2099 - 2106
Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale Yoshiaki KubotaTakeshi YamamotoWataru Shimizu Study Protocol Open access 10 August 2018 Pages: 2107 - 2116
Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy Hisamitsu IshiharaMotonobu AnaiMasayo Yamada Study Protocol Open access 25 August 2018 Pages: 2117 - 2125
Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study Maya MatsushitaDaisuke ChujoHiroshi Kajio Brief Report Open access 28 July 2018 Pages: 2127 - 2132
Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study György JermendyZoltán KissPéter Kempler Brief Report Open access 17 August 2018 Pages: 2133 - 2141
Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program Jennifer D. GoldmanJasvinder GillWilliam H. Polonsky Brief Report Open access 14 September 2018 Pages: 2143 - 2153
Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L Ariel ZismanTerry DexVanita R. Aroda Brief Report Open access 14 September 2018 Pages: 2155 - 2162
Reassessing Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus: A Brief Updated Analytical Report (2015–2017) Xia DaiZu-chun LuoFeng Huang Brief Report Open access 15 September 2018 Pages: 2163 - 2171
Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report Goran PetrovskiFawziya Al KhalafJudith Campbell Case Report Open access 20 July 2018 Pages: 2173 - 2177
Successful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy Ting ChenDandan ZhangLinqi Chen Case Report Open access 09 August 2018 Pages: 2179 - 2184